STOCK TITAN

Nutrien Ltd. SEC Filings

NTR NYSE

Welcome to our dedicated page for Nutrien Ltd. SEC filings (Ticker: NTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nutrien Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nutrien Ltd.'s regulatory disclosures and financial reporting.

Rhea-AI Summary

Nutrien Ltd. reported much stronger results for 2025, driven by higher fertilizer prices and solid volumes across its Potash, Nitrogen and Retail businesses. Full-year sales reached $26.9 billion, up 4% from 2024, while gross margin rose 11% to $8.3 billion. Net earnings climbed to $2.3 billion, compared with $0.7 billion a year earlier, and diluted net earnings per share increased to $4.66 from $1.36. Adjusted EBITDA grew 13% to $6.0 billion and adjusted net earnings per share rose 31% to $4.56, reflecting stronger underlying operations.

In the fourth quarter, net earnings were $0.58 billion, or $1.18 per diluted share, and adjusted EBITDA was $1.28 billion with adjusted EPS of $0.83. Results benefited from higher potash net selling prices, increased potash volumes and improved upstream fertilizer performance, partly offset by lower Nitrogen volumes and softer Retail earnings. Net income also included a gain on the sale of Nutrien’s 50% investment in Profertil.

For 2026, Nutrien targets Retail adjusted EBITDA of $1.75 billion to $1.95 billion, potash sales of 14.1 to 14.8 million tonnes, nitrogen sales of 9.2 to 9.7 million tonnes and capital expenditures of $2.0 to $2.1 billion, assuming an effective tax rate on adjusted net earnings of 24% to 26%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
current report
-
Rhea-AI Summary

Nutrien Ltd. is increasing cash returns to shareholders by raising its quarterly dividend and planning a new share repurchase program. The Board declared a quarterly dividend of US$0.55 per share, payable on April 16, 2026 to shareholders of record on March 31, 2026, an increase of about one percent from the prior dividend and equal to an annualized US$2.20 per share.

The Board also approved the purchase of up to five percent of issued and outstanding common shares over a twelve-month period through a normal course issuer bid, subject to acceptance by the Toronto Stock Exchange. The dividend will be paid in Canadian or US dollars depending on shareholder residency and intermediaries, with options to elect currency and direct deposit. All dividends are designated as eligible dividends under Canadian tax law.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
current report
-
Rhea-AI Summary

BlackRock, Inc. filed an amended ownership report showing it beneficially owns 23,787,129 shares of Nutrien Ltd. common stock, representing 4.9% of the class as of the reported date. BlackRock reports sole voting power over 22,161,123 shares and sole dispositive power over 23,787,129 shares, with no shared voting or dispositive power.

The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Nutrien. It also notes that various underlying persons have rights to dividends or sale proceeds, but no individual person has more than five percent of the total outstanding common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.39%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.94%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.71%
Tags
current report
-
Rhea-AI Summary

BlackRock, Inc. filed a Schedule 13G reporting beneficial ownership of 24,820,750 shares of Nutrien Ltd. (NTR), representing 5.1% of the common stock as of the event date 09/30/2025.

BlackRock reports sole voting power over 22,762,839 shares and sole dispositive power over 24,820,750 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
current report

FAQ

How many Nutrien Ltd. (NTR) SEC filings are available on StockTitan?

StockTitan tracks 29 SEC filings for Nutrien Ltd. (NTR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Nutrien Ltd. (NTR)?

The most recent SEC filing for Nutrien Ltd. (NTR) was filed on February 18, 2026.